GMV applied to FDA for this specific use of the Patch (for Covid patients in hospitals) and got emergency clearance for that.
They obviously did their homework in defining the specific urgent need and providing the solution that was compelling enough for the FDA to approve quickly.
The Factsheet also indicates the medical community is realising the benefits of this type of remote monitoring. It makes it easier to sell the Patch to hospitals if they know they need it, rather than try and convince them they should get it.
GMV Price at posting:
7.2¢ Sentiment: Hold Disclosure: Held